Biologix showcased its leadership in hematology at the 3rd Middle East Masterclass in Hematology (MEMAC), held on 9–10 January 2026 at the Raffles Hotel, Dubai, UAE. The congress brought together leading hematology experts from across the region for two days of scientific exchange and collaboration.
Organized with the International Academy for Clinical Hematology (IACH), the masterclass focused on the latest evidence-based advances in leukemia, lymphoma, multiple myeloma, and other hematological disorders. Biologix’s participation underscores its commitment to advancing medical education, supporting innovation, and improving patient care across the region.
